Opioid Prescriptions and Pain-Related Patient-Initiated Communication After Mohs Micrographic Surgery: A Retrospective Cohort Study

May 2022 | Volume 21 | Issue 5 | 551 | Copyright © May 2022


Published online May 1, 2022

Christian Carr , Oliver Taylor , Antonio Garcia , Sophia Tran , Divya Srivastava , Rajiv I Nijhawan

Department of Dermatology, University of Texas Southwestern Medical School, Dallas, TX

indicating that patients at higher risk of reporting pain are being appropriately identified. However, additional counseling that pain is still likely but just more tolerable may be beneficial. Limitations include low power for assessing certain operative characteristics since pain is infrequent following MMS, and that this study was conducted retrospectively at a single institution.

DISCLOSURES

The authors report no relevant conflicts of interest.

REFERENCES

1. Limthongkul B, Samie F, Humphreys TR. Assessment of postoperative pain after Mohs micrographic surgery. Dermatol Surg. 2013;39(6):857-63.
2. Cao S, Karmouta R, Li DG, et al. Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population. JAMA Dermatol. 2018. 154(3):317-322.
3. Kreicher KL, Bordeaux JS. Addressing Practice Gaps in Cutaneous Surgery: Advances in Diagnosis and Treatment. JAMA Facial Plast Surg. 2017;19(2):147-154.
4. McLawhorn JM, Stephany MP, Bruhn WE, et al., An expert panel consensus on opioid-prescribing guidelines for dermatologic procedures. JAMA Dermatol. 2020;82(3):700-708.
5. Donigan JM, Srivastava D, Maher I, et al, Opioid Prescribing recommendations after mohs micrographic surgery and reconstruction: a delphi consensus. Dermatol Surg. 2020 Aug 3. Online ahead of print.
6. Chitgopeker P, Sidey K, Aronson A, et al. Factors associated with patientinitiated communication after mohs micrographic surgery. Dermatol Surg. 2019;45(2):234-243.

AUTHOR CORRESPONDENCE

Rajiv I. Nijhawan MD rajiv.nijhawan@utsw.edu